Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Managing opioid withdrawal in the ED: Best practices for buprenorphine induction.

JAAPA : official journal of the American Academy of Physician Assistants·2025
Same author

Physician Assistant/Associate School Interviews: Here, There, or Elsewhere?

The journal of physician assistant education : the official journal of the Physician Assistant Education Association·2025
Same author

Analysis of Institutional Financial Stability and Physician Assistant Program Accreditation Outcomes.

The journal of physician assistant education : the official journal of the Physician Assistant Education Association·2025
Same author

Association Between Physician Assistant Program Characteristics and Student Diversity.

The journal of physician assistant education : the official journal of the Physician Assistant Education Association·2025
Same author

Do Physician Assistant Professional Doctorate Missions and Learning Outcomes Align With the Physician Assistant Professional Competencies?

The journal of physician assistant education : the official journal of the Physician Assistant Education Association·2025
Same author

Smoking Behavior and Social Identity: Correlates of Phantom Smoking Among Lesbian, Gay, Bisexual, Transgender, and Other Sexual and Gender Diverse Young Adults.

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco·2024

Related Experiment Video

Updated: Mar 13, 2026

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.8K

Sharpening the attack on non-small cell lung cancer.

Allison Alexander1, Brenda Quincy

  • 1At the time this article was written, Allison Alexander was a student in the PA program at Elon (N.C.) University. She now practices family medicine in Angier, N.C. Brenda Quincy is an associate professor at Butler University in Indianapolis, Ind. The authors have disclosed no potential conflicts of interest, financial or otherwise.

JAAPA : Official Journal of the American Academy of Physician Assistants
|October 28, 2016
PubMed
Summary

Targeted therapies are revolutionizing advanced non-small cell lung cancer (NSCLC) treatment by targeting specific driver mutations. This approach offers new hope for improved outcomes in NSCLC patients.

More Related Videos

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

11.1K
A Minimally Invasive Method for Generating a Syngeneic Orthotopic Mouse Model of Lung Cancer
07:46

A Minimally Invasive Method for Generating a Syngeneic Orthotopic Mouse Model of Lung Cancer

Published on: August 19, 2025

1.8K

Related Experiment Videos

Last Updated: Mar 13, 2026

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.8K
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

11.1K
A Minimally Invasive Method for Generating a Syngeneic Orthotopic Mouse Model of Lung Cancer
07:46

A Minimally Invasive Method for Generating a Syngeneic Orthotopic Mouse Model of Lung Cancer

Published on: August 19, 2025

1.8K

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Advanced non-small cell lung cancer (NSCLC) historically presents limited therapeutic options and poor prognoses.
  • Recent advancements in understanding NSCLC molecular pathology have unveiled critical driver mutations.
  • These mutations are key drivers of uncontrolled cancer cell proliferation.

Purpose of the Study:

  • To review the current standard treatments for NSCLC.
  • To explore targetable mutations within NSCLC.
  • To discuss available targeted therapies, challenges, and future directions for NSCLC treatment.

Main Methods:

  • Literature review of standard NSCLC treatments.
  • Analysis of research on NSCLC molecular drivers.
  • Compilation of data on targeted therapies and their efficacy.
  • Discussion of treatment obstacles and future prospects.

Main Results:

  • Identification of specific driver mutations in NSCLC.
  • Development of targeted therapies that inhibit these mutations.
  • Demonstration of halted cancer progression in patients receiving targeted treatments.
  • Recognition of existing challenges in implementing targeted therapy.

Conclusions:

  • Targeted therapies represent a paradigm shift in treating advanced NSCLC.
  • Precision medicine approaches hold significant promise for improving patient outcomes.
  • Continued research is essential to overcome treatment obstacles and advance NSCLC care.